Blue Diamond Ventures Inc (BLDV)

[JPS02]

BLDV Provides Updates for Shareholders

Blue Diamond Ventures Inc. will start Audited Books on July 1st 2018

June 12, 2018 Blue Diamond Ventures Inc. (OTC PK: BLDV) Denver Colorado:

June 30th will be end-of-year, BLDV will return to July 1st Fiscal Year

Blue Diamond Ventures Inc. has announced an upcoming merger with Cann10 North America, and although the date is not set, on July 1st BLDV will move one step closer to goal of SEC Reporting by bringing in a new financial team (attorney & accountant) that will be responsible for compiling the audited accounts that will lead to SEC Reporting, and the potential to up-list to the CSE.

The focus of the company is increasingly on pharma-grade cannabis engagements, and non-contributing holdings are being eliminated in favor of expanded emphasis on consulting, project management and equity partnerships in cultivation and processing. The process is being driven by licensed technologies coming from Israel in collaboration with USA & Canadian Tech firms.

Our previous attorney was unable to provide a letter to certify the 2017 Year-End numbers due to unforeseen circumstances, and the company was forced to accept a Yield Sign, indicating limited information. In addition, due to the change in fiscal year end, the Q1 (January 1st 2018 to March 31th 2018), is late, and will be filed together with Q2 (April 1st 2018 to June 30th 2018), on July 15th 2018. This will be a Year-End report and the new books will start on July 1st 2018.

All filings will be done by July 15th 2018 and the company will return to PINK-Current Information.

Statement from Josh Alper CEO: “We thank you for your patience, as we understand that the Limited Information status makes our offering appear to be troubled, I can assure you that BLDV continues to build our position in the medical / pharmaceutical cannabis industry with strong partners and relationships that will add value to the stock. We are proceeding slowing to specifically protect the shareholders during this important transition.”

About BLDV: Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable pharmaceutical-grade cannabis products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. Blue Diamond Ventures, Inc. seeks opportunities in medical cannabis markets and is driven by critical thinking and the scientific method.

Safe Harbor: This press release contains forward-looking statements. Such forward-looking statements are subject to several risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:
Blue Diamond Ventures Inc.
535 N. Michigan Avenue, Suite 3001, Chicago, Illinois, 60611
Joshua B. Alper Chief Executive Officer
[phone] [e-mail] www.bldvinc.com

Source: https://backend.otcmarkets.com/otcapi/company/dns/news/document/31455/content

- I think this is one of the most important updates that I have seen from BLDV as it confirms that BLDV is:

1. Pursuing SEC reporting status that will start on July 1, 2018. This objective involves a significant amount of time and money that otc tickers do not do for nothing. I am thinking the Cann10 NA merger is the main impetus for this objective, notice how they are mentioned in the same paragraph. This is what I suspected previously, link back to my previous post.

2. Planning to file the missing financial reports by July 15, 2018 to return to pink current status. This was a relief to see.

3. Continuing through with the Cann10 NA merger. As PinkPaste pointed out the wording of "an upcoming merger" is now being used by BLDV. I think this is a strong hint combined with the SEC reporting objective!

4. Possibly pursuing a potential uplisting to the CSE. This is no easy task which would attract a whole different group of investors if achieved.

5. Continuing to focus on medical and pharma-grade cannabis. Although it would have been nice to see follow through and achievement of the previous initiatives they communicated to us which the spent time and money on, I guess at this point focusing on whatever is now more important and will add value is the wise option with Cann10 NA in the picture. Let's just get it done!

- What I found interesting was how BLDV mentioned equity partnerships in cultivation followed by the sentence that the process is being driven by licensed technologies coming from Israel in collaboration with USA & Canadian Tech firms. I think this is key and what will drive value into the stock in the future as long as they achieve what they are communicating.

I am very happy to see this update as long as BLDV can follow through and make it happen.

Go BLDV!